SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-318232
Filing Date
2020-12-15
Accepted
2020-12-15 17:29:29
Documents
7
Effectiveness Date
2020-12-15

Document Format Files

Seq Description Document Type Size
1 S-8 d28592ds8.htm S-8 78446
2 EX-5.1 d28592dex51.htm EX-5.1 13137
3 EX-23.2 d28592dex232.htm EX-23.2 1843
4 EX-99.2(A) d28592dex992a.htm EX-99.2(A) 115647
5 EX-99.3 d28592dex993.htm EX-99.3 69688
6 GRAPHIC g28592dsp13a.jpg GRAPHIC 3838
7 GRAPHIC g28592dsp14a.jpg GRAPHIC 2899
  Complete submission text file 0001193125-20-318232.txt   289443
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-251370 | Film No.: 201390542
SIC: 2836 Biological Products, (No Diagnostic Substances)